Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Ono and GSK sign agreement for Ono-4128

Jan. 21, 2003

Chiron to transfer SILCAAT study to trial investigators

Jan. 20, 2003

Novel HIV protease inhibitors in early development at Merck

Jan. 17, 2003

NIH grant to support development of UC-781

Jan. 15, 2003

Safety of WHI-05 and WHI-07 demonstrated preclinically

Jan. 14, 2003

Triangle files MAA for emtricitabine

Jan. 13, 2003

U.S. and E.U. filings made for HIV treatment GW-433908

Jan. 2, 2003

BMS submits NDA for atazanavir for treatment of HIV

Jan. 2, 2003

AVI BioPharma and International Therapeutics to develop NeuGene compounds for HIV

Dec. 27, 2002

AIDSVAX B/E and AIDSVAX B/B receive fast track designation

Dec. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...